Texcef TZ 500mg/62.5mg Injection
Marketer
Aarotax Pharmaceutical Pvt Ltd
Salt Composition
Ceftriaxone (500mg) + Tazobactum (62.5mg)
Overview Texcef TZ 500mg/62.5mg Injection
Cefixime and Sulbactam injection (500mg/62.5mg), sold as Texcef TZ, combats various bacterial infections by inhibiting microbial growth and propagation. This combination medication requires administration by a healthcare professional. Consistent adherence to the prescribed dosage schedule is crucial, completing the entire course even with symptom improvement. Premature cessation may compromise its effectiveness. Commonly reported side effects include nausea, vomiting, diarrhea, and indigestion. Severe or worsening side effects necessitate immediate medical attention. Allergic reactions (rash, itching, swelling, breathing difficulties) require prompt emergency care. Inform your doctor of all other medications and health conditions before commencing treatment. Pregnant or lactating individuals should consult their doctor prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, avoid driving if drowsiness or dizziness occurs. Adequate rest, a balanced diet, and sufficient hydration are recommended for optimal recovery. Your physician may order tests to monitor the medication's effects.
Primary Ingredients of Texcef TZ 500mg/62.5mg Injection
No information provided. A rephrased text cannot be generated.
Uses of Texcef TZ 500mg/62.5mg Injection
Infections caused by bacteria
Major Benefits of Texcef TZ 500mg/62.5mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Texcef TZ 500mg/62.5mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Texcef TZ 500mg/62.5mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Texcef TZ 500mg/62.5mg Injection works:
Ceftriaxone and Tazobactum, combined as Texcef TZ 500mg/62.5mg Injection, offer a dual-action approach to bacterial infection. Ceftriaxone, a crucial antibiotic component, disrupts bacterial cell wall synthesis, hindering their ability to survive. The addition of Tazobactum, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby amplifying Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Texcef TZ 500mg/62.5mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Texcef TZ (500mg/62.5mg) is typically deemed safe for use during gestation. Preclinical trials in animals have revealed minimal or no negative impacts on fetal development; nevertheless, clinical data from human subjects are scarce.
Breast feedingCAUTION
The administration of Texcef TZ 500mg/62.5mg Injection necessitates careful consideration while breastfeeding. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Texcef TZ 500mg/62.5mg Injection can lead to drowsiness, blurred vision, or dizziness. Operating a vehicle is inadvisable if these side effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Texcef TZ 500mg/62.5mg Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCAUTION
The injectable formulation of Texcef TZ (500mg/62.5mg) requires careful administration in individuals with significant hepatic impairment, potentially necessitating dosage modification. A physician's consultation is advised. Dosage alteration for Texcef TZ (500mg/62.5mg) injection is unnecessary in patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Texcef TZ 500mg/62.5mg Injection :
Omitting a scheduled dose of Texcef TZ 500mg/62.5mg Injection necessitates contacting your physician.
Facts to Know About Texcef TZ 500mg/62.5mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
3,018 People bought this recently